Prior to phosphoproteomics analysis, an optimal time point for selinexor stimulation was determined by treating sensitive MV-4-11 human AML cells with 1 μM selinexor and monitor the relative phosphorylation of S780-Rb for up to 0.5–8 h. This evidence concerns the gene RB1 and acute myeloid leukemia.